{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:01:56Z","timestamp":1787500916730,"version":"build-2736575974"},"reference-count":140,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,8]],"date-time":"2021-03-08T00:00:00Z","timestamp":1615161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,3,8]],"date-time":"2021-03-08T00:00:00Z","timestamp":1615161600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["GCRC grant (No. 2011-0030001)"],"award-info":[{"award-number":["GCRC grant (No. 2011-0030001)"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["BK21 FOUR Program (5120200513755)"],"award-info":[{"award-number":["BK21 FOUR Program (5120200513755)"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Precis. Onc."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The inflammatory tumor microenvironment has been known to be closely connected to all stages of cancer development, including initiation, promotion, and progression. Systemic inflammation in the tumor microenvironment is increasingly being recognized as an important prognostic marker in cancer patients. Inflammasomes are master regulators in the first line of host defense for the initiation of innate immune responses. Inflammasomes sense pathogen-associated molecular patterns and damage-associated molecular patterns, following recruitment of immune cells into infection sites. Therefore, dysregulated expression\/activation of inflammasomes is implicated in pathogenesis of diverse inflammatory disorders. Recent studies have demonstrated that inflammasomes play a vital role in regulating the development and progression of cancer. This review focuses on fate-determining roles of the inflammasomes and the principal downstream effector cytokine, IL-1\u03b2, in the tumor microenvironment.<\/jats:p>","DOI":"10.1038\/s41698-021-00154-7","type":"journal-article","created":{"date-parts":[[2021,3,8]],"date-time":"2021-03-08T06:03:05Z","timestamp":1615183385000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":66,"title":["Dynamic roles of inflammasomes in inflammatory tumor microenvironment"],"prefix":"10.1038","volume":"5","author":[{"given":"Jeong-Hoon","family":"Jang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Do-Hee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Joon","family":"Surh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,8]]},"reference":[{"key":"154_CR1","doi-asserted-by":"publisher","first-page":"5591","DOI":"10.1242\/jcs.116392","volume":"125","author":"FR Balkwill","year":"2012","unstructured":"Balkwill, F. R., Capasso, M. & Hagemann, T. The tumor microenvironment at a glance. J. Cell Sci. 125, 5591\u20135596 (2012).","journal-title":"J. Cell Sci."},{"key":"154_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.critrevonc.2007.07.004","volume":"66","author":"P Allavena","year":"2008","unstructured":"Allavena, P., Sica, A., Solinas, G., Porta, C. & Mantovani, A. The inflammatory micro-environment in tumor progression: the role of tumor-associated macrophages. Crit. Rev. Oncol. Hematol. 66, 1\u20139 (2008).","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"154_CR3","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.cell.2010.03.014","volume":"141","author":"BZ Qian","year":"2010","unstructured":"Qian, B. Z. & Pollard, J. W. Macrophage diversity enhances tumor progression and metastasis. Cell 141, 39\u201351 (2010).","journal-title":"Cell"},{"key":"154_CR4","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1159\/000092969","volume":"13","author":"KE de Visser","year":"2006","unstructured":"de Visser, K. E. & Coussens, L. M. The inflammatory tumor microenvironment and its impact on cancer development. Contrib. Microbiol. 13, 118\u2013137 (2006).","journal-title":"Contrib. Microbiol"},{"key":"154_CR5","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1146\/annurev.immunol.021908.132612","volume":"27","author":"CA Dinarello","year":"2009","unstructured":"Dinarello, C. A. Immunological and inflammatory functions of the interleukin-1 family. Annu. Rev. Immunol. 27, 519\u2013550 (2009).","journal-title":"Annu. Rev. Immunol."},{"key":"154_CR6","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s13238-013-0001-4","volume":"5","author":"R Kolb","year":"2014","unstructured":"Kolb, R., Liu, G. H., Janowski, A. M., Sutterwala, F. S. & Zhang, W. Inflammasomes in cancer: a double-edged sword. Protein Cell 5, 12\u201320 (2014).","journal-title":"Protein Cell"},{"key":"154_CR7","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/ni.2224","volume":"13","author":"L Zitvogel","year":"2012","unstructured":"Zitvogel, L., Kepp, O., Galluzzi, L. & Kroemer, G. Inflammasomes in carcinogenesis and anticancer immune responses. Nat. Immunol. 13, 343\u2013351 (2012).","journal-title":"Nat. Immunol."},{"key":"154_CR8","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.cell.2010.01.040","volume":"140","author":"K Schroder","year":"2010","unstructured":"Schroder, K. & Tschopp, J. The inflammasomes. Cell 140, 821\u2013832 (2010).","journal-title":"Cell"},{"key":"154_CR9","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/nm.3893","volume":"21","author":"H Guo","year":"2015","unstructured":"Guo, H., Callaway, J. B. & Ting, J. P. Inflammasomes: mechanism of action, role in disease, and therapeutics. Nat. Med. 21, 677\u2013687 (2015).","journal-title":"Nat. Med"},{"key":"154_CR10","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1038\/ni1276","volume":"6","author":"CN Serhan","year":"2005","unstructured":"Serhan, C. N. & Savill, J. Resolution of inflammation: the beginning programs the end. Nat. Immunol. 6, 1191\u20131197 (2005).","journal-title":"Nat. Immunol."},{"key":"154_CR11","doi-asserted-by":"publisher","first-page":"160","DOI":"10.3389\/fimmu.2016.00160","volume":"7","author":"MA Sugimoto","year":"2016","unstructured":"Sugimoto, M. A., Sousa, L. P., Pinho, V., Perretti, M. & Teixeira, M. M. Resolution of inflammation: what controls its onset? Front. Immunol. 7, 160 (2016).","journal-title":"Front. Immunol."},{"key":"154_CR12","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1038\/emboj.2009.163","volume":"28","author":"P Pelegrin","year":"2009","unstructured":"Pelegrin, P. & Surprenant, A. Dynamics of macrophage polarization reveal new mechanism to inhibit IL-1beta release through pyrophosphates. EMBO J. 28, 2114\u20132127 (2009).","journal-title":"EMBO J."},{"key":"154_CR13","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21590","volume":"70","author":"RL Siegel","year":"2020","unstructured":"Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2020. CA Cancer J. Clin. 70, 7\u201330 (2020).","journal-title":"CA Cancer J. Clin."},{"key":"154_CR14","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/s41572-019-0111-2","volume":"5","author":"N Harbeck","year":"2019","unstructured":"Harbeck, N. et al. Breast cancer. Nat. Rev. Dis. Prim. 5, 66 (2019).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"154_CR15","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nature17676","volume":"534","author":"S Nik-Zainal","year":"2016","unstructured":"Nik-Zainal, S. et al. Landscape of somatic mutations in 560 breast cancer whole-genome sequences. Nature 534, 47\u201354 (2016).","journal-title":"Nature"},{"key":"154_CR16","doi-asserted-by":"publisher","first-page":"27990","DOI":"10.18632\/oncotarget.15856","volume":"8","author":"Q Wu","year":"2017","unstructured":"Wu, Q. et al. Breast cancer subtypes predict the preferential site of distant metastases: a SEER based study. Oncotarget 8, 27990\u201327996 (2017).","journal-title":"Oncotarget"},{"key":"154_CR17","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1126\/science.1203543","volume":"331","author":"CL Chaffer","year":"2011","unstructured":"Chaffer, C. L. & Weinberg, R. A. A perspective on cancer cell metastasis. Science 331, 1559\u20131564 (2011).","journal-title":"Science"},{"key":"154_CR18","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1158\/0008-5472.CAN-19-2288","volume":"80","author":"JH Jang","year":"2020","unstructured":"Jang, J. H. et al. Breast cancer cell-derived soluble CD44 promotes tumor progression by triggering macrophage IL1beta production. Cancer Res. 80, 1342\u20131356 (2020).","journal-title":"Cancer Res."},{"key":"154_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/bcr1648","volume":"9","author":"C Chavey","year":"2007","unstructured":"Chavey, C. et al. Oestrogen receptor negative breast cancers exhibit high cytokine content. Breast Cancer Res. 9, R15 (2007).","journal-title":"Breast Cancer Res."},{"key":"154_CR20","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1158\/1078-0432.CCR-18-2202","volume":"25","author":"C Tulotta","year":"2019","unstructured":"Tulotta, C. et al. Endogenous production of IL1B by breast cancer cells drives metastasis and colonization of the bone microenvironment. Clin. Cancer Res. 25, 2769\u20132782 (2019).","journal-title":"Clin. Cancer Res."},{"key":"154_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12807-0","volume":"10","author":"R Eyre","year":"2019","unstructured":"Eyre, R. et al. Microenvironmental IL1beta promotes breast cancer metastatic colonisation in the bone via activation of Wnt signalling. Nat. Commun. 10, 5016 (2019).","journal-title":"Nat. Commun."},{"key":"154_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/srep36107","volume":"6","author":"B Guo","year":"2016","unstructured":"Guo, B., Fu, S., Zhang, J., Liu, B. & Li, Z. Targeting inflammasome\/IL-1 pathways for cancer immunotherapy. Sci. Rep. 6, 36107 (2016).","journal-title":"Sci. Rep."},{"key":"154_CR23","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1530\/ERC-13-0158","volume":"21","author":"F Nutter","year":"2014","unstructured":"Nutter, F. et al. Different molecular profiles are associated with breast cancer cell homing compared with colonisation of bone: evidence using a novel bone-seeking cell line. Endocr. Relat. Cancer 21, 327\u2013341 (2014).","journal-title":"Endocr. Relat. Cancer"},{"key":"154_CR24","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1056\/NEJMoa1105195","volume":"365","author":"RE Coleman","year":"2011","unstructured":"Coleman, R. E. et al. Breast-cancer adjuvant therapy with zoledronic acid. N. Engl. J. Med. 365, 1396\u20131405 (2011).","journal-title":"N. Engl. J. Med."},{"key":"154_CR25","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1073\/pnas.1812266115","volume":"116","author":"I Kaplanov","year":"2019","unstructured":"Kaplanov, I. et al. Blocking IL-1beta reverses the immunosuppression in mouse breast cancer and synergizes with anti-PD-1 for tumor abrogation. Proc. Natl Acad. Sci. USA 116, 1361\u20131369 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"154_CR26","doi-asserted-by":"publisher","first-page":"75571","DOI":"10.18632\/oncotarget.12289","volume":"7","author":"I Holen","year":"2016","unstructured":"Holen, I. et al. IL-1 drives breast cancer growth and bone metastasis in vivo. Oncotarget 7, 75571\u201375584 (2016).","journal-title":"Oncotarget"},{"key":"154_CR27","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1038\/nm.2028","volume":"15","author":"F Ghiringhelli","year":"2009","unstructured":"Ghiringhelli, F. et al. Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors. Nat. Med. 15, 1170\u20131178 (2009).","journal-title":"Nat. Med."},{"key":"154_CR28","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1007\/s00262-017-2020-0","volume":"66","author":"SJ Storr","year":"2017","unstructured":"Storr, S. J. et al. Macrophage-derived interleukin-1beta promotes human breast cancer cell migration and lymphatic adhesion in vitro. Cancer Immunol. Immunother. 66, 1287\u20131294 (2017).","journal-title":"Cancer Immunol. Immunother."},{"key":"154_CR29","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.4049\/jimmunol.1002720","volume":"186","author":"G Guarda","year":"2011","unstructured":"Guarda, G. et al. Differential expression of NLRP3 among hematopoietic cells. J. Immunol. 186, 2529\u20132534 (2011).","journal-title":"J. Immunol."},{"key":"154_CR30","doi-asserted-by":"publisher","first-page":"5243","DOI":"10.1158\/0008-5472.CAN-18-0413","volume":"78","author":"TC Wu","year":"2018","unstructured":"Wu, T. C. et al. IL1 receptor antagonist controls transcriptional signature of inflammation in patients with metastatic breast cancer. Cancer Res. 78, 5243\u20135258 (2018).","journal-title":"Cancer Res."},{"key":"154_CR31","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ccr.2009.06.018","volume":"16","author":"DG DeNardo","year":"2009","unstructured":"DeNardo, D. G. et al. CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages. Cancer Cell 16, 91\u2013102 (2009).","journal-title":"Cancer Cell"},{"key":"154_CR32","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1084\/jem.20061120","volume":"204","author":"C Aspord","year":"2007","unstructured":"Aspord, C. et al. Breast cancer instructs dendritic cells to prime interleukin 13-secreting CD4+ T cells that facilitate tumor development. J. Exp. Med. 204, 1037\u20131047 (2007).","journal-title":"J. Exp. Med."},{"key":"154_CR33","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.bbrc.2017.06.117","volume":"490","author":"AM Jimenez-Garduno","year":"2017","unstructured":"Jimenez-Garduno, A. M. et al. IL-1beta induced methylation of the estrogen receptor ERalpha gene correlates with EMT and chemoresistance in breast cancer cells. Biochem. Biophys. Res. Commun. 490, 780\u2013785 (2017).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"154_CR34","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/s41586-019-1450-6","volume":"572","author":"MD Wellenstein","year":"2019","unstructured":"Wellenstein, M. D. et al. Loss of p53 triggers WNT-dependent systemic inflammation to drive breast cancer metastasis. Nature 572, 538\u2013542 (2019).","journal-title":"Nature"},{"key":"154_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13007","volume":"7","author":"R Kolb","year":"2016","unstructured":"Kolb, R. et al. Obesity-associated NLRC4 inflammasome activation drives breast cancer progression. Nat. Commun. 7, 13007 (2016).","journal-title":"Nat. Commun."},{"key":"154_CR36","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1038\/s41556-018-0173-5","volume":"20","author":"Z Castano","year":"2018","unstructured":"Castano, Z. et al. IL-1beta inflammatory response driven by primary breast cancer prevents metastasis-initiating cell colonization. Nat. Cell Biol. 20, 1084\u20131097 (2018).","journal-title":"Nat. Cell Biol."},{"key":"154_CR37","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1158\/1535-7163.MCT-14-0969","volume":"14","author":"T Voloshin","year":"2015","unstructured":"Voloshin, T. et al. Blocking IL1beta pathway following paclitaxel chemotherapy slightly inhibits primary tumor growth but promotes spontaneous metastasis. Mol. Cancer Ther. 14, 1385\u20131394 (2015).","journal-title":"Mol. Cancer Ther."},{"key":"154_CR38","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1158\/1055-9965.EPI-17-0876","volume":"27","author":"CN Kuo","year":"2018","unstructured":"Kuo, C. N., Pan, J. J., Huang, Y. W., Tsai, H. J. & Chang, W. C. Association between nonsteroidal anti-inflammatory drugs and colorectal cancer: a population-based case-control study. Cancer Epidemiol. Biomark. Prev. 27, 737\u2013745 (2018).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"154_CR39","doi-asserted-by":"publisher","unstructured":"Roelands, J. et al. Immunogenomic classification of colorectal cancer and therapeutic implications. Int. J. Mol. Sci. 18, https:\/\/doi.org\/10.3390\/ijms18102229 (2017).","DOI":"10.3390\/ijms18102229"},{"key":"154_CR40","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1158\/1078-0432.CCR-05-1603","volume":"12","author":"DM Elaraj","year":"2006","unstructured":"Elaraj, D. M. et al. The role of interleukin 1 in growth and metastasis of human cancer xenografts. Clin. Cancer Res. 12, 1088\u20131096 (2006).","journal-title":"Clin. Cancer Res."},{"key":"154_CR41","doi-asserted-by":"publisher","first-page":"4084","DOI":"10.18632\/aging.101695","volume":"10","author":"H Qian","year":"2018","unstructured":"Qian, H., Zhang, D. & Bao, C. Two variants of interleukin-1B gene are associated with the decreased risk, clinical features, and better overall survival of colorectal cancer: a two-center case-control study. Aging (Albany NY) 10, 4084\u20134092 (2018).","journal-title":"Aging (Albany NY)"},{"key":"154_CR42","doi-asserted-by":"publisher","first-page":"3369","DOI":"10.4049\/jimmunol.1402098","volume":"194","author":"TM Williams","year":"2015","unstructured":"Williams, T. M. et al. The NLRP1 inflammasome attenuates colitis and colitis-associated tumorigenesis. J. Immunol. 194, 3369\u20133380 (2015).","journal-title":"J. Immunol."},{"key":"154_CR43","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1084\/jem.20100050","volume":"207","author":"IC Allen","year":"2010","unstructured":"Allen, I. C. et al. The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer. J. Exp. Med. 207, 1045\u20131056 (2010).","journal-title":"J. Exp. Med."},{"key":"154_CR44","doi-asserted-by":"publisher","first-page":"21635","DOI":"10.1073\/pnas.1016814108","volume":"107","author":"B Hu","year":"2010","unstructured":"Hu, B. et al. Inflammation-induced tumorigenesis in the colon is regulated by caspase-1 and NLRC4. Proc. Natl Acad. Sci. USA 107, 21635\u201321640 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"154_CR45","doi-asserted-by":"publisher","first-page":"7187","DOI":"10.4049\/jimmunol.1100412","volume":"186","author":"GY Chen","year":"2011","unstructured":"Chen, G. Y., Liu, M., Wang, F., Bertin, J. & Nunez, G. A functional role for Nlrp6 in intestinal inflammation and tumorigenesis. J. Immunol. 186, 7187\u20137194 (2011).","journal-title":"J. Immunol."},{"key":"154_CR46","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.4161\/cc.10.12.16008","volume":"10","author":"B Hu","year":"2011","unstructured":"Hu, B., Elinav, E. & Flavell, R. A. Inflammasome-mediated suppression of inflammation-induced colorectal cancer progression is mediated by direct regulation of epithelial cell proliferation. Cell Cycle 10, 1936\u20131939 (2011).","journal-title":"Cell Cycle"},{"key":"154_CR47","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/sj.onc.1208201","volume":"24","author":"S Sadasivam","year":"2005","unstructured":"Sadasivam, S. et al. Caspase-1 activator Ipaf is a p53-inducible gene involved in apoptosis. Oncogene 24, 627\u2013636 (2005).","journal-title":"Oncogene"},{"key":"154_CR48","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1038\/mi.2013.126","volume":"7","author":"Y Wang","year":"2014","unstructured":"Wang, Y. et al. Neutrophil infiltration favors colitis-associated tumorigenesis by activating the interleukin-1 (IL-1)\/IL-6 axis. Mucosal Immunol. 7, 1106\u20131115 (2014).","journal-title":"Mucosal Immunol."},{"key":"154_CR49","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1038\/mi.2015.18","volume":"8","author":"C Ning","year":"2015","unstructured":"Ning, C. et al. Complement activation promotes colitis-associated carcinogenesis through activating intestinal IL-1beta\/IL-17A axis. Mucosal Immunol. 8, 1275\u20131284 (2015).","journal-title":"Mucosal Immunol."},{"key":"154_CR50","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1158\/2326-6066.CIR-18-0766","volume":"7","author":"Y Toyoshima","year":"2019","unstructured":"Toyoshima, Y. et al. IL6 modulates the immune status of the tumor microenvironment to facilitate metastatic colonization of colorectal cancer cells. Cancer Immunol. Res. 7, 1944\u20131957 (2019).","journal-title":"Cancer Immunol. Res."},{"key":"154_CR51","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ccr.2009.01.001","volume":"15","author":"S Grivennikov","year":"2009","unstructured":"Grivennikov, S. et al. IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer Cell 15, 103\u2013113 (2009).","journal-title":"Cancer Cell"},{"key":"154_CR52","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.4049\/jimmunol.0801217","volume":"184","author":"S Matsumoto","year":"2010","unstructured":"Matsumoto, S. et al. Essential roles of IL-6 trans-signaling in colonic epithelial cells, induced by the IL-6\/soluble-IL-6 receptor derived from lamina propria macrophages, on the development of colitis-associated premalignant cancer in a murine model. J. Immunol. 184, 1543\u20131551 (2010).","journal-title":"J. Immunol."},{"key":"154_CR53","first-page":"560","volume":"118","author":"BK Popivanova","year":"2008","unstructured":"Popivanova, B. K. et al. Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis. J. Clin. Invest. 118, 560\u2013570 (2008).","journal-title":"J. Clin. Invest."},{"key":"154_CR54","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1093\/carcin\/bgs106","volume":"33","author":"YS Hyun","year":"2012","unstructured":"Hyun, Y. S. et al. Role of IL-17A in the development of colitis-associated cancer. Carcinogenesis 33, 931\u2013936 (2012).","journal-title":"Carcinogenesis"},{"key":"154_CR55","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/nrc3775","volume":"14","author":"Z Chen","year":"2014","unstructured":"Chen, Z., Fillmore, C. M., Hammerman, P. S., Kim, C. F. & Wong, K. K. Non-small-cell lung cancers: a heterogeneous set of diseases. Nat. Rev. Cancer 14, 535\u2013546 (2014).","journal-title":"Nat. Rev. Cancer"},{"key":"154_CR56","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0139073","volume":"10","author":"GA Banat","year":"2015","unstructured":"Banat, G. A. et al. Immune and inflammatory cell composition of human lung cancer stroma. PLoS ONE 10, e0139073 (2015).","journal-title":"PLoS ONE"},{"key":"154_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14381","volume":"8","author":"J Kargl","year":"2017","unstructured":"Kargl, J. et al. Neutrophils dominate the immune cell composition in non-small cell lung cancer. Nat. Commun. 8, 14381 (2017).","journal-title":"Nat. Commun."},{"key":"154_CR58","doi-asserted-by":"publisher","first-page":"58181","DOI":"10.18632\/oncotarget.11276","volume":"7","author":"M Terlizzi","year":"2016","unstructured":"Terlizzi, M., Colarusso, C., Popolo, A., Pinto, A. & Sorrentino, R. IL-1alpha and IL-1beta-producing macrophages populate lung tumor lesions in mice. Oncotarget 7, 58181\u201358192 (2016).","journal-title":"Oncotarget"},{"key":"154_CR59","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0205242","volume":"13","author":"I Lasithiotaki","year":"2018","unstructured":"Lasithiotaki, I. et al. NLRP3\/Caspase-1 inflammasome activation is decreased in alveolar macrophages in patients with lung cancer. PLoS ONE 13, e0205242 (2018).","journal-title":"PLoS ONE"},{"key":"154_CR60","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.celrep.2016.05.085","volume":"16","author":"AG McLoed","year":"2016","unstructured":"McLoed, A. G. et al. Neutrophil-derived IL-1beta impairs the efficacy of NF-kappaB inhibitors against lung cancer. Cell Rep. 16, 120\u2013132 (2016).","journal-title":"Cell Rep."},{"key":"154_CR61","doi-asserted-by":"publisher","first-page":"3462","DOI":"10.4049\/jimmunol.1002901","volume":"186","author":"Y Carmi","year":"2011","unstructured":"Carmi, Y. et al. Microenvironment-derived IL-1 and IL-17 interact in the control of lung metastasis. J. Immunol. 186, 3462\u20133471 (2011).","journal-title":"J. Immunol."},{"key":"154_CR62","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1111\/j.1349-7006.2003.tb01428.x","volume":"94","author":"S Yano","year":"2003","unstructured":"Yano, S. et al. Multifunctional interleukin-1beta promotes metastasis of human lung cancer cells in SCID mice via enhanced expression of adhesion-, invasion- and angiogenesis-related molecules. Cancer Sci. 94, 244\u2013252 (2003).","journal-title":"Cancer Sci."},{"key":"154_CR63","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.sder.2011.08.003","volume":"30","author":"HE Kanavy","year":"2011","unstructured":"Kanavy, H. E. & Gerstenblith, M. R. Ultraviolet radiation and melanoma. Semin. Cutan. Med. Surg. 30, 222\u2013228 (2011).","journal-title":"Semin. Cutan. Med. Surg."},{"key":"154_CR64","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.bbrc.2016.06.106","volume":"477","author":"T Hasegawa","year":"2016","unstructured":"Hasegawa, T., Nakashima, M. & Suzuki, Y. Nuclear DNA damage-triggered NLRP3 inflammasome activation promotes UVB-induced inflammatory responses in human keratinocytes. Biochem. Biophys. Res. Commun. 477, 329\u2013335 (2016).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"154_CR65","first-page":"55","volume":"17","author":"I Elamin","year":"2008","unstructured":"Elamin, I., Zecevic, R. D., Vojvodic, D., Medenica, L. & Pavlovic, M. D. Cytokine concentrations in basal cell carcinomas of different histological types and localization. Acta Dermatovenerol. Alp. Pannonica Adriat. 17, 55\u201359 (2008).","journal-title":"Acta Dermatovenerol. Alp. Pannonica Adriat."},{"key":"154_CR66","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.canlet.2007.05.013","volume":"256","author":"D Raman","year":"2007","unstructured":"Raman, D., Baugher, P. J., Thu, Y. M. & Richmond, A. Role of chemokines in tumor growth. Cancer Lett. 256, 137\u2013165 (2007).","journal-title":"Cancer Lett."},{"key":"154_CR67","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.canlet.2011.10.001","volume":"314","author":"JH Dunn","year":"2012","unstructured":"Dunn, J. H., Ellis, L. Z. & Fujita, M. Inflammasomes as molecular mediators of inflammation and cancer: potential role in melanoma. Cancer Lett. 314, 24\u201333 (2012).","journal-title":"Cancer Lett."},{"key":"154_CR68","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1093\/jnci\/88.3-4.198","volume":"88","author":"F Vidal-Vanaclocha","year":"1996","unstructured":"Vidal-Vanaclocha, F. et al. Interleukin 1 (IL-1)-dependent melanoma hepatic metastasis in vivo; increased endothelial adherence by IL-1-induced mannose receptors and growth factor production in vitro. J. Natl Cancer Inst. 88, 198\u2013205 (1996).","journal-title":"J. Natl Cancer Inst."},{"key":"154_CR69","first-page":"2667","volume":"54","author":"F Vidal-Vanaclocha","year":"1994","unstructured":"Vidal-Vanaclocha, F., Amezaga, C., Asumendi, A., Kaplanski, G. & Dinarello, C. A. Interleukin-1 receptor blockade reduces the number and size of murine B16 melanoma hepatic metastases. Cancer Res. 54, 2667\u20132672 (1994).","journal-title":"Cancer Res."},{"key":"154_CR70","first-page":"4768","volume":"51","author":"FJ Burrows","year":"1991","unstructured":"Burrows, F. J. et al. Influence of tumor-derived interleukin 1 on melanoma-endothelial cell interactions in vitro. Cancer Res. 51, 4768\u20134775 (1991).","journal-title":"Cancer Res."},{"key":"154_CR71","doi-asserted-by":"publisher","first-page":"6477","DOI":"10.1074\/jbc.M109.064907","volume":"285","author":"M Okamoto","year":"2010","unstructured":"Okamoto, M. et al. Constitutively active inflammasome in human melanoma cells mediating autoinflammation via caspase-1 processing and secretion of interleukin-1beta. J. Biol. Chem. 285, 6477\u20136488 (2010).","journal-title":"J. Biol. Chem."},{"key":"154_CR72","doi-asserted-by":"publisher","first-page":"6448","DOI":"10.4049\/jimmunol.171.12.6448","volume":"171","author":"X Song","year":"2003","unstructured":"Song, X. et al. Differential effects of IL-1 alpha and IL-1 beta on tumorigenicity patterns and invasiveness. J. Immunol. 171, 6448\u20136456 (2003).","journal-title":"J. Immunol."},{"key":"154_CR73","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1073\/pnas.0437939100","volume":"100","author":"E Voronov","year":"2003","unstructured":"Voronov, E. et al. IL-1 is required for tumor invasiveness and angiogenesis. Proc. Natl Acad. Sci. USA 100, 2645\u20132650 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"154_CR74","doi-asserted-by":"publisher","first-page":"18384","DOI":"10.1073\/pnas.1209171109","volume":"109","author":"SK Drexler","year":"2012","unstructured":"Drexler, S. K. et al. Tissue-specific opposing functions of the inflammasome adaptor ASC in the regulation of epithelial skin carcinogenesis. Proc. Natl Acad. Sci. USA 109, 18384\u201318389 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"154_CR75","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/jid.2012.317","volume":"133","author":"W Liu","year":"2013","unstructured":"Liu, W. et al. Dual role of apoptosis-associated speck-like protein containing a CARD (ASC) in tumorigenesis of human melanoma. J. Invest. Dermatol. 133, 518\u2013527 (2013).","journal-title":"J. Invest. Dermatol."},{"key":"154_CR76","doi-asserted-by":"publisher","first-page":"3820","DOI":"10.1038\/onc.2017.26","volume":"36","author":"Z Zhai","year":"2017","unstructured":"Zhai, Z. et al. NLRP1 promotes tumor growth by enhancing inflammasome activation and suppressing apoptosis in metastatic melanoma. Oncogene 36, 3820\u20133830 (2017).","journal-title":"Oncogene"},{"key":"154_CR77","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1038\/icb.2012.46","volume":"90","author":"MT Chow","year":"2012","unstructured":"Chow, M. T., Tschopp, J., Moller, A. & Smyth, M. J. NLRP3 promotes inflammation-induced skin cancer but is dispensable for asbestos-induced mesothelioma. Immunol. Cell Biol. 90, 983\u2013986 (2012).","journal-title":"Immunol. Cell Biol."},{"key":"154_CR78","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003330","volume":"9","author":"AA Negash","year":"2013","unstructured":"Negash, A. A. et al. IL-1beta production through the NLRP3 inflammasome by hepatic macrophages links hepatitis C virus infection with liver inflammation and disease. PLoS Pathog. 9, e1003330 (2013).","journal-title":"PLoS Pathog."},{"key":"154_CR79","doi-asserted-by":"publisher","first-page":"12284","DOI":"10.1128\/JVI.01962-13","volume":"87","author":"S Shrivastava","year":"2013","unstructured":"Shrivastava, S., Mukherjee, A., Ray, R. & Ray, R. B. Hepatitis C virus induces interleukin-1beta (IL-1beta)\/IL-18 in circulatory and resident liver macrophages. J. Virol. 87, 12284\u201312290 (2013).","journal-title":"J. Virol."},{"key":"154_CR80","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1002\/hep.29681","volume":"67","author":"J Zhang","year":"2018","unstructured":"Zhang, J. et al. Hypoxia-inducible factor-1alpha\/interleukin-1beta signaling enhances hepatoma epithelial-mesenchymal transition through macrophages in a hypoxic-inflammatory microenvironment. Hepatology 67, 1872\u20131889 (2018).","journal-title":"Hepatology"},{"key":"154_CR81","first-page":"6002","volume":"11","author":"B Yu","year":"2018","unstructured":"Yu, B. et al. High expression of IL-1beta and NFkappaB in tumor tissue predicts a low recurrence rate of hepatocellular carcinoma. Int. J. Clin. Exp. Pathol. 11, 6002\u20136009 (2018).","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"154_CR82","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/labinvest.2013.126","volume":"94","author":"Q Wei","year":"2014","unstructured":"Wei, Q. et al. Deregulation of the NLRP3 inflammasome in hepatic parenchymal cells during liver cancer progression. Lab Invest. 94, 52\u201362 (2014).","journal-title":"Lab Invest"},{"key":"154_CR83","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.jhep.2013.03.033","volume":"59","author":"C Brenner","year":"2013","unstructured":"Brenner, C., Galluzzi, L., Kepp, O. & Kroemer, G. Decoding cell death signals in liver inflammation. J. Hepatol. 59, 583\u2013594 (2013).","journal-title":"J. Hepatol."},{"key":"154_CR84","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.3899\/jrheum.090074","volume":"36","author":"M Mertens","year":"2009","unstructured":"Mertens, M. & Singh, J. A. Anakinra for rheumatoid arthritis: a systematic review. J. Rheumatol. 36, 1118\u20131125 (2009).","journal-title":"J. Rheumatol."},{"key":"154_CR85","doi-asserted-by":"publisher","first-page":"85","DOI":"10.5152\/eurjrheum.2019.18190","volume":"6","author":"A Berdeli","year":"2019","unstructured":"Berdeli, A., Senol, O. & Talay, G. Treatment of familial mediterranean fever with canakinumab in patients who are unresponsive to colchicine. Eur. J. Rheumatol. 6, 85\u201388 (2019).","journal-title":"Eur. J. Rheumatol."},{"key":"154_CR86","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.coph.2004.03.010","volume":"4","author":"CA Dinarello","year":"2004","unstructured":"Dinarello, C. A. Therapeutic strategies to reduce IL-1 activity in treating local and systemic inflammation. Curr. Opin. Pharm. 4, 378\u2013385 (2004).","journal-title":"Curr. Opin. Pharm."},{"key":"154_CR87","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0099568","volume":"9","author":"K Watari","year":"2014","unstructured":"Watari, K. et al. Tumor-derived interleukin-1 promotes lymphangiogenesis and lymph node metastasis through M2-type macrophages. PLoS ONE 9, e99568 (2014).","journal-title":"PLoS ONE"},{"key":"154_CR88","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1158\/1078-0432.CCR-14-3382","volume":"22","author":"Z Zhuang","year":"2016","unstructured":"Zhuang, Z. et al. IL1 receptor antagonist inhibits pancreatic cancer growth by abrogating NF-kappaB activation. Clin. Cancer Res. 22, 1432\u20131444 (2016).","journal-title":"Clin. Cancer Res"},{"key":"154_CR89","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1016\/S0140-6736(17)32247-X","volume":"390","author":"PM Ridker","year":"2017","unstructured":"Ridker, P. M. et al. Effect of interleukin-1beta inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial. Lancet 390, 1833\u20131842 (2017).","journal-title":"Lancet"},{"key":"154_CR90","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2018.1474319","volume":"7","author":"N Isambert","year":"2018","unstructured":"Isambert, N. et al. Fluorouracil and bevacizumab plus anakinra for patients with metastatic colorectal cancer refractory to standard therapies (IRAFU): a single-arm phase 2 study. Oncoimmunology 7, e1474319 (2018).","journal-title":"Oncoimmunology"},{"key":"154_CR91","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1056\/NEJMoa1414325","volume":"372","author":"RJ Mayer","year":"2015","unstructured":"Mayer, R. J. et al. Randomized trial of TAS-102 for refractory metastatic colorectal cancer. N. Engl. J. Med. 372, 1909\u20131919 (2015).","journal-title":"N. Engl. J. Med."},{"key":"154_CR92","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/S0140-6736(12)61900-X","volume":"381","author":"A Grothey","year":"2013","unstructured":"Grothey, A. et al. Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial. Lancet 381, 303\u2013312 (2013).","journal-title":"Lancet"},{"key":"154_CR93","doi-asserted-by":"publisher","first-page":"309","DOI":"10.3389\/fnmol.2018.00309","volume":"11","author":"N Kerr","year":"2018","unstructured":"Kerr, N. et al. Inflammasome proteins in serum and serum-derived extracellular vesicles as biomarkers of stroke. Front. Mol. Neurosci. 11, 309 (2018).","journal-title":"Front. Mol. Neurosci."},{"key":"154_CR94","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.3171\/2012.9.JNS12815","volume":"117","author":"S Adamczak","year":"2012","unstructured":"Adamczak, S. et al. Inflammasome proteins in cerebrospinal fluid of brain-injured patients as biomarkers of functional outcome: clinical article. J. Neurosurg. 117, 1119\u20131125 (2012).","journal-title":"J. Neurosurg."},{"key":"154_CR95","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3389\/fneur.2018.00135","volume":"9","author":"RW Keane","year":"2018","unstructured":"Keane, R. W., Dietrich, W. D. & de Rivero Vaccari, J. P. Inflammasome proteins as biomarkers of multiple sclerosis. Front. Neurol. 9, 135 (2018).","journal-title":"Front. Neurol."},{"key":"154_CR96","doi-asserted-by":"publisher","unstructured":"Scott, X. O. et al. The inflammasome adaptor protein ASC in mild cognitive impairment and Alzheimer\u2019s disease. Int. J. Mol. Sci. 21, https:\/\/doi.org\/10.3390\/ijms21134674 (2020).","DOI":"10.3390\/ijms21134674"},{"key":"154_CR97","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.mgene.2013.12.002","volume":"2","author":"IA Bhat","year":"2014","unstructured":"Bhat, I. A. et al. Association of interleukin 1 beta (IL-1beta) polymorphism with mRNA expression and risk of non small cell lung cancer. Meta Gene 2, 123\u2013133 (2014).","journal-title":"Meta Gene"},{"key":"154_CR98","doi-asserted-by":"publisher","first-page":"971","DOI":"10.3389\/fonc.2019.00971","volume":"9","author":"YY Wang","year":"2019","unstructured":"Wang, Y. Y., Liu, X. L. & Zhao, R. Induction of pyroptosis and its implications in cancer management. Front. Oncol. 9, 971 (2019).","journal-title":"Front. Oncol."},{"key":"154_CR99","doi-asserted-by":"publisher","unstructured":"Zheng, Z. & Li, G. Mechanisms and therapeutic regulation of pyroptosis in inflammatory diseases and cancer. Int. J. Mol. Sci. 21, https:\/\/doi.org\/10.3390\/ijms21041456 (2020).","DOI":"10.3390\/ijms21041456"},{"key":"154_CR100","doi-asserted-by":"publisher","first-page":"109595","DOI":"10.1016\/j.biopha.2019.109595","volume":"121","author":"Y Fang","year":"2020","unstructured":"Fang, Y. et al. Pyroptosis: a new frontier in cancer. Biomed. Pharmacother. 121, 109595 (2020).","journal-title":"Biomed. Pharmacother."},{"key":"154_CR101","doi-asserted-by":"publisher","first-page":"406","DOI":"10.7150\/ijbs.23542","volume":"14","author":"F Wang","year":"2018","unstructured":"Wang, F. et al. Simvastatin suppresses proliferation and migration in non-small cell lung cancer via pyroptosis. Int J. Biol. Sci. 14, 406\u2013417 (2018).","journal-title":"Int J. Biol. Sci."},{"key":"154_CR102","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.3727\/096504016X14813859905646","volume":"25","author":"Z Jiang","year":"2017","unstructured":"Jiang, Z. et al. miRNA-214 inhibits cellular proliferation and migration in glioma cells targeting caspase 1 involved in pyroptosis. Oncol. Res. 25, 1009\u20131019 (2017).","journal-title":"Oncol. Res."},{"key":"154_CR103","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.3389\/fimmu.2017.01132","volume":"8","author":"M Kantono","year":"2017","unstructured":"Kantono, M. & Guo, B. Inflammasomes and cancer: The dynamic role of the inflammasome in tumor development. Front. Immunol. 8, 1132 (2017).","journal-title":"Front. Immunol"},{"key":"154_CR104","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1091\/mbc.02-02-0023","volume":"13","author":"X Chen","year":"2002","unstructured":"Chen, X. et al. Gene expression patterns in human liver cancers. Mol. Biol. Cell 13, 1929\u20131939 (2002).","journal-title":"Mol. Biol. Cell"},{"key":"154_CR105","doi-asserted-by":"publisher","first-page":"85","DOI":"10.2119\/molmed.2008.00110","volume":"15","author":"VR Mas","year":"2009","unstructured":"Mas, V. R. et al. Genes involved in viral carcinogenesis and tumor initiation in hepatitis C virus-induced hepatocellular carcinoma. Mol. Med. 15, 85\u201394 (2009).","journal-title":"Mol. Med."},{"key":"154_CR106","doi-asserted-by":"publisher","DOI":"10.1186\/1755-8794-1-13","volume":"1","author":"AI Riker","year":"2008","unstructured":"Riker, A. I. et al. The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis. BMC Med. Genomics 1, 13 (2008).","journal-title":"BMC Med. Genomics"},{"key":"154_CR107","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-5-30","volume":"5","author":"I Nindl","year":"2006","unstructured":"Nindl, I. et al. Identification of differentially expressed genes in cutaneous squamous cell carcinoma by microarray expression profiling. Mol. Cancer 5, 30 (2006).","journal-title":"Mol. Cancer"},{"key":"154_CR108","doi-asserted-by":"publisher","first-page":"7234","DOI":"10.1158\/1078-0432.CCR-05-0683","volume":"11","author":"D Talantov","year":"2005","unstructured":"Talantov, D. et al. Novel genes associated with malignant melanoma but not benign melanocytic lesions. Clin. Cancer Res. 11, 7234\u20137242 (2005).","journal-title":"Clin. Cancer Res."},{"key":"154_CR109","doi-asserted-by":"publisher","first-page":"13790","DOI":"10.1073\/pnas.191502998","volume":"98","author":"A Bhattacharjee","year":"2001","unstructured":"Bhattacharjee, A. et al. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc. Natl Acad. Sci. USA 98, 13790\u201313795 (2001).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"154_CR110","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2007-8-7-r131","volume":"8","author":"S Kaiser","year":"2007","unstructured":"Kaiser, S. et al. Transcriptional recapitulation and subversion of embryonic colon development by mouse colon tumor models and human colon cancer. Genome Biol. 8, R131 (2007).","journal-title":"Genome Biol."},{"key":"154_CR111","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.2353\/ajpath.2008.070851","volume":"172","author":"C Gaspar","year":"2008","unstructured":"Gaspar, C. et al. Cross-species comparison of human and mouse intestinal polyps reveals conserved mechanisms in adenomatous polyposis coli (APC)-driven tumorigenesis. Am. J. Pathol. 172, 1363\u20131380 (2008).","journal-title":"Am. J. Pathol."},{"key":"154_CR112","doi-asserted-by":"publisher","unstructured":"Skrzypczak, M. et al. Modeling oncogenic signaling in colon tumors by multidirectional analyses of microarray data directed for maximization of analytical reliability. PLoS ONE 5, https:\/\/doi.org\/10.1371\/journal.pone.0013091 (2010).","DOI":"10.1371\/journal.pone.0013091"},{"key":"154_CR113","doi-asserted-by":"publisher","first-page":"2523","DOI":"10.1091\/mbc.e03-11-0786","volume":"15","author":"H Zhao","year":"2004","unstructured":"Zhao, H. et al. Different gene expression patterns in invasive lobular and ductal carcinomas of the breast. Mol. Biol. Cell 15, 2523\u20132536 (2004).","journal-title":"Mol. Biol. Cell"},{"key":"154_CR114","doi-asserted-by":"publisher","DOI":"10.1186\/bcr2222","volume":"11","author":"XJ Ma","year":"2009","unstructured":"Ma, X. J., Dahiya, S., Richardson, E., Erlander, M. & Sgroi, D. C. Gene expression profiling of the tumor microenvironment during breast cancer progression. Breast Cancer Res. 11, R7 (2009).","journal-title":"Breast Cancer Res."},{"key":"154_CR115","doi-asserted-by":"publisher","first-page":"10202","DOI":"10.1158\/0008-5472.CAN-10-2607","volume":"70","author":"S Roessler","year":"2010","unstructured":"Roessler, S. et al. A unique metastasis gene signature enables prediction of tumor relapse in early-stage hepatocellular carcinoma patients. Cancer Res. 70, 10202\u201310212 (2010).","journal-title":"Cancer Res."},{"key":"154_CR116","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0001651","volume":"3","author":"MT Landi","year":"2008","unstructured":"Landi, M. T. et al. Gene expression signature of cigarette smoking and its role in lung adenocarcinoma development and survival. PLoS ONE 3, e1651 (2008).","journal-title":"PLoS ONE"},{"key":"154_CR117","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0010312","volume":"5","author":"J Hou","year":"2010","unstructured":"Hou, J. et al. Gene expression-based classification of non-small cell lung carcinomas and survival prediction. PLoS ONE 5, e10312 (2010).","journal-title":"PLoS ONE"},{"key":"154_CR118","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s10585-010-9305-4","volume":"27","author":"Y Hong","year":"2010","unstructured":"Hong, Y., Downey, T., Eu, K. W., Koh, P. K. & Cheah, P. Y. A \u2018metastasis-prone\u2019 signature for early-stage mismatch-repair proficient sporadic colorectal cancer patients and its implications for possible therapeutics. Clin. Exp. Metastasis 27, 83\u201390 (2010).","journal-title":"Clin. Exp. Metastasis"},{"key":"154_CR119","doi-asserted-by":"publisher","first-page":"11005","DOI":"10.1073\/pnas.0500904102","volume":"102","author":"L Radvanyi","year":"2005","unstructured":"Radvanyi, L. et al. The gene associated with trichorhinophalangeal syndrome in humans is overexpressed in breast cancer. Proc. Natl Acad. Sci. USA 102, 11005\u201311010 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"154_CR120","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1007\/s10549-011-1412-7","volume":"132","author":"S Gluck","year":"2012","unstructured":"Gluck, S. et al. TP53 genomics predict higher clinical and pathologic tumor response in operable early-stage breast cancer treated with docetaxel-capecitabine +\/- trastuzumab. Breast Cancer Res. Treat. 132, 781\u2013791 (2012).","journal-title":"Breast Cancer Res. Treat."},{"key":"154_CR121","doi-asserted-by":"publisher","first-page":"4205","DOI":"10.1093\/bioinformatics\/bti688","volume":"21","author":"S Wachi","year":"2005","unstructured":"Wachi, S., Yoneda, K. & Wu, R. Interactome-transcriptome analysis reveals the high centrality of genes differentially expressed in lung cancer tissues. Bioinformatics 21, 4205\u20134208 (2005).","journal-title":"Bioinformatics"},{"key":"154_CR122","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1002\/gcc.20811","volume":"49","author":"J Gaedcke","year":"2010","unstructured":"Gaedcke, J. et al. Mutated KRAS results in overexpression of DUSP4, a MAP-kinase phosphatase, and SMYD3, a histone methyltransferase, in rectal carcinomas. Genes Chromosomes Cancer 49, 1024\u20131034 (2010).","journal-title":"Genes Chromosomes Cancer"},{"key":"154_CR123","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/nm1764","volume":"14","author":"G Finak","year":"2008","unstructured":"Finak, G. et al. Stromal gene expression predicts clinical outcome in breast cancer. Nat. Med. 14, 518\u2013527 (2008).","journal-title":"Nat. Med."},{"key":"154_CR124","doi-asserted-by":"publisher","first-page":"6092","DOI":"10.1073\/pnas.0501564102","volume":"102","author":"C Haqq","year":"2005","unstructured":"Haqq, C. et al. The gene expression signatures of melanoma progression. Proc. Natl Acad. Sci. USA 102, 6092\u20136097 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"154_CR125","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1002\/ijc.22975","volume":"121","author":"DH Ki","year":"2007","unstructured":"Ki, D. H. et al. Whole genome analysis for liver metastasis gene signatures in colorectal cancer. Int. J. Cancer 121, 2005\u20132012 (2007).","journal-title":"Int. J. Cancer"},{"key":"154_CR126","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1158\/1078-0432.CCR-06-1633","volume":"13","author":"Y Hong","year":"2007","unstructured":"Hong, Y., Ho, K. S., Eu, K. W. & Cheah, P. Y. A susceptibility gene set for early onset colorectal cancer that integrates diverse signaling pathways: implication for tumorigenesis. Clin. Cancer Res. 13, 1107\u20131114 (2007).","journal-title":"Clin. Cancer Res."},{"key":"154_CR127","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nature10983","volume":"486","author":"C Curtis","year":"2012","unstructured":"Curtis, C. et al. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature 486, 346\u2013352 (2012).","journal-title":"Nature"},{"key":"154_CR128","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/35021093","volume":"406","author":"CM Perou","year":"2000","unstructured":"Perou, C. M. et al. Molecular portraits of human breast tumours. Nature 406, 747\u2013752 (2000).","journal-title":"Nature"},{"key":"154_CR129","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/nature06188","volume":"449","author":"AE Karnoub","year":"2007","unstructured":"Karnoub, A. E. et al. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 449, 557\u2013563 (2007).","journal-title":"Nature"},{"key":"154_CR130","doi-asserted-by":"publisher","first-page":"10869","DOI":"10.1073\/pnas.191367098","volume":"98","author":"T Sorlie","year":"2001","unstructured":"Sorlie, T. et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc. Natl Acad. Sci. USA 98, 10869\u201310874 (2001).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"154_CR131","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1158\/0008-5472.CAN-11-1403","volume":"72","author":"H Okayama","year":"2012","unstructured":"Okayama, H. et al. Identification of genes upregulated in ALK-positive and EGFR\/KRAS\/ALK-negative lung adenocarcinomas. Cancer Res. 72, 100\u2013111 (2012).","journal-title":"Cancer Res"},{"key":"154_CR132","doi-asserted-by":"publisher","first-page":"369","DOI":"10.3389\/fphar.2016.00369","volume":"7","author":"F Kong","year":"2016","unstructured":"Kong, F. et al. Curcumin represses NLRP3 inflammasome activation via TLR4\/MyD88\/NF-kappaB and P2X7R signaling in PMA-induced macrophages. Front. Pharm. 7, 369 (2016).","journal-title":"Front. Pharm."},{"key":"154_CR133","doi-asserted-by":"publisher","first-page":"2835","DOI":"10.4049\/jimmunol.1701495","volume":"200","author":"H Yin","year":"2018","unstructured":"Yin, H. et al. Curcumin suppresses IL-1beta secretion and prevents inflammation through inhibition of the NLRP3 inflammasome. J. Immunol. 200, 2835\u20132846 (2018).","journal-title":"J. Immunol."},{"key":"154_CR134","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.molimm.2018.09.004","volume":"104","author":"Z Gong","year":"2018","unstructured":"Gong, Z. et al. Curcumin alleviates DSS-induced colitis via inhibiting NLRP3 inflammsome activation and IL-1beta production. Mol. Immunol. 104, 11\u201319 (2018).","journal-title":"Mol. Immunol."},{"key":"154_CR135","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1093\/intimm\/dxv018","volume":"27","author":"T Misawa","year":"2015","unstructured":"Misawa, T. et al. Resveratrol inhibits the acetylated alpha-tubulin-mediated assembly of the NLRP3-inflammasome. Int. Immunol. 27, 425\u2013434 (2015).","journal-title":"Int. Immunol."},{"key":"154_CR136","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1177\/1753425913507096","volume":"20","author":"TT Huang","year":"2014","unstructured":"Huang, T. T. et al. cis-Resveratrol produces anti-inflammatory effects by inhibiting canonical and non-canonical inflammasomes in macrophages. Innate Immun. 20, 735\u2013750 (2014).","journal-title":"Innate Immun."},{"key":"154_CR137","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neurobiolaging.2015.10.016","volume":"38","author":"YW An","year":"2016","unstructured":"An, Y. W., Jhang, K. A., Woo, S. Y., Kang, J. L. & Chong, Y. H. Sulforaphane exerts its anti-inflammatory effect against amyloid-beta peptide via STAT-1 dephosphorylation and activation of Nrf2\/HO-1 cascade in human THP-1 macrophages. Neurobiol. Aging 38, 1\u201310 (2016).","journal-title":"Neurobiol. Aging"},{"key":"154_CR138","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1189\/jlb.3A0415-155RR","volume":"99","author":"AJ Greaney","year":"2016","unstructured":"Greaney, A. J., Maier, N. K., Leppla, S. H. & Moayeri, M. Sulforaphane inhibits multiple inflammasomes through an Nrf2-independent mechanism. J. Leukoc. Biol. 99, 189\u2013199 (2016).","journal-title":"J. Leukoc. Biol."},{"key":"154_CR139","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1007\/s00018-017-2720-9","volume":"75","author":"L Chen","year":"2018","unstructured":"Chen, L. et al. Blockage of the NLRP3 inflammasome by MCC950 improves anti-tumor immune responses in head and neck squamous cell carcinoma. Cell Mol. Life Sci. 75, 2045\u20132058 (2018).","journal-title":"Cell Mol. Life Sci."},{"key":"154_CR140","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.1158\/0008-5472.CAN-11-1947","volume":"72","author":"E Adinolfi","year":"2012","unstructured":"Adinolfi, E. et al. Expression of P2X7 receptor increases in vivo tumor growth. Cancer Res. 72, 2957\u20132969 (2012).","journal-title":"Cancer Res."}],"container-title":["npj Precision Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41698-021-00154-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41698-021-00154-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41698-021-00154-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,29]],"date-time":"2023-01-29T14:11:51Z","timestamp":1675001511000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41698-021-00154-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,8]]},"references-count":140,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["154"],"URL":"https:\/\/doi.org\/10.1038\/s41698-021-00154-7","relation":{},"ISSN":["2397-768X"],"issn-type":[{"value":"2397-768X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,8]]},"assertion":[{"value":"10 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18"}}